<VariationArchive VariationID="420068" VariationName="NM_001126128.2(PROK2):c.297dup (p.Gly100fs)" VariationType="Duplication" Accession="VCV000420068" Version="7" RecordType="classified" NumberOfSubmissions="6" NumberOfSubmitters="6" DateLastUpdated="2024-06-23" DateCreated="2017-04-27" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="406363" VariationID="420068">
      <GeneList>
        <Gene Symbol="PROK2" FullName="prokineticin 2" GeneID="60675" HGNC_ID="HGNC:18455" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>3p13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="71771655" stop="71785148" display_start="71771655" display_stop="71785148" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="71820805" stop="71834356" display_start="71820805" display_stop="71834356" Strand="-" />
          </Location>
          <OMIM>607002</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001126128.2(PROK2):c.297dup (p.Gly100fs)</Name>
      <CanonicalSPDI>NC_000003.12:71772816:AAAAAA:AAAAAAA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>3p13</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="71772816" stop="71772817" display_start="71772816" display_stop="71772817" variantLength="1" positionVCF="71772816" referenceAlleleVCF="C" alternateAlleleVCF="CA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="71821967" stop="71821968" display_start="71821967" display_stop="71821968" variantLength="1" positionVCF="71821967" referenceAlleleVCF="C" alternateAlleleVCF="CA" />
      </Location>
      <ProteinChange>G100fs</ProteinChange>
      <ProteinChange>G79fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001126128.1" sequenceAccession="NM_001126128" sequenceVersion="1" change="c.297dupT">
            <Expression>NM_001126128.1:c.297dupT</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.11" sequenceAccession="NC_000003" sequenceVersion="11" change="g.71821973dup" Assembly="GRCh37">
            <Expression>NC_000003.11:g.71821973dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.12" sequenceAccession="NC_000003" sequenceVersion="12" change="g.71772822dup" Assembly="GRCh38">
            <Expression>NC_000003.12:g.71772822dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008275.1" sequenceAccession="NG_008275" sequenceVersion="1" change="g.17390dup">
            <Expression>NG_008275.1:g.17390dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001126128.2" sequenceAccession="NM_001126128" sequenceVersion="2" change="c.297dup" MANESelect="true">
            <Expression>NM_001126128.2:c.297dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001119600.1" sequenceAccession="NP_001119600" sequenceVersion="1" change="p.Gly100fs">
            <Expression>NP_001119600.1:p.Gly100fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_021935.4" sequenceAccession="NM_021935" sequenceVersion="4" change="c.234dup">
            <Expression>NM_021935.4:c.234dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_068754.1" sequenceAccession="NP_068754" sequenceVersion="1" change="p.Gly79fs">
            <Expression>NP_068754.1:p.Gly79fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001126128.2" sequenceAccession="NM_001126128" sequenceVersion="2" change="c.297dupT" MANESelect="true">
            <Expression>NM_001126128.2:c.297dupT</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA2491964" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="607002.0002" DB="OMIM" />
        <XRef Type="rs" ID="768413190" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001126128.2(PROK2):c.297dup (p.Gly100fs) AND not provided" Accession="RCV000486838" Version="4">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, conflicting classifications</ReviewStatus>
            <Description DateLastEvaluated="2024-01-21" SubmissionCount="3">Conflicting interpretations of pathogenicity</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001126128.2(PROK2):c.297dup (p.Gly100fs) AND Hypogonadotropic hypogonadism 4 with or without anosmia" Accession="RCV002295299" Version="1">
        <ClassifiedConditionList TraitSetID="946">
          <ClassifiedCondition DB="MedGen" ID="C3552343">Hypogonadotropic hypogonadism 4 with or without anosmia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2006-10-20" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001126128.2(PROK2):c.297dup (p.Gly100fs) AND not specified" Accession="RCV003401531" Version="1">
        <ClassifiedConditionList TraitSetID="9590">
          <ClassifiedCondition DB="MedGen" ID="CN169374">not specified</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-10-03" SubmissionCount="1">Uncertain significance</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001126128.2(PROK2):c.297dup (p.Gly100fs) AND PROK2-related disorder" Accession="RCV003419793" Version="5">
        <ClassifiedConditionList TraitSetID="91595">
          <ClassifiedCondition>PROK2-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-08-10" SubmissionCount="1">Uncertain significance</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-01-21" NumberOfSubmissions="6" NumberOfSubmitters="6" DateCreated="2017-04-27" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, conflicting classifications</ReviewStatus>
        <Description>Conflicting classifications of pathogenicity</Description>
        <Explanation DataSource="ClinVar" Type="public">Pathogenic(1); Uncertain significance(4)</Explanation>
        <Citation Type="general">
          <ID Source="PubMed">17054399</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18682503</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20022991</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31200363</ID>
        </Citation>
        <Comment DataSource="ClinVar" Type="public">Pathogenic(1); Uncertain significance(4)</Comment>
        <DescriptionHistory Dated="2024-02-25">
          <Description>Uncertain significance</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2022-11-05">
          <Description>Uncertain significance</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2022-11-05">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2021-09-25">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="946" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="1881" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">KAL4</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">HYPOGONADOTROPIC HYPOGONADISM 4 WITH ANOSMIA</ElementValue>
                <XRef Type="Allelic variant" ID="607002.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607002.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607002.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607002.0005" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Kallmann syndrome 4</ElementValue>
                <XRef ID="Kallmann+syndrome+4/8703" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hypogonadotropic hypogonadism 4 with or without anosmia</ElementValue>
                <XRef ID="MONDO:0012528" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">HH4</ElementValue>
                <XRef Type="MIM" ID="610628" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10772" />
                <XRef ID="10772" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">PROK2-Related GnRH Deficiency (Kallmann Syndrome 4)</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Isolated gonadotropin-releasing hormone (GnRH) deficiency (IGD) is characterized by inappropriately low serum concentrations of the gonadotropins LH (luteinizing hormone) and FSH (follicle-stimulating hormone) in the presence of low circulating concentrations of sex steroids. IGD is associated with a normal sense of smell (normosmic IGD) in approximately 40% of affected individuals and an impaired sense of smell (Kallmann syndrome) in approximately 60%. IGD can first become apparent in infancy, adolescence, or adulthood. Infant boys with congenital IGD often have micropenis and cryptorchidism. Adolescents and adults with IGD have clinical evidence of hypogonadism and incomplete sexual maturation on physical examination. Adult males with IGD tend to have prepubertal testicular volume (i.e., &lt;4 mL), absence of secondary sexual features (e.g., facial and axillary hair growth, deepening of the voice), decreased muscle mass, diminished libido, erectile dysfunction, and infertility. Adult females have little or no breast development and primary amenorrhea. Although skeletal maturation is delayed, the rate of linear growth is usually normal except for the absence of a distinct pubertal growth spurt.</Attribute>
                <XRef ID="NBK1334" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">PROK2-Related Isolated Gonadotropin-Releasing Hormone (GnRH) Deficiency</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301509</ID>
                <ID Source="BookShelf">NBK1334</ID>
              </Citation>
              <XRef ID="478" DB="Orphanet" />
              <XRef ID="C3552343" DB="MedGen" />
              <XRef ID="MONDO:0012528" DB="MONDO" />
              <XRef Type="MIM" ID="610628" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="91595" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="71171" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">PROK2-related disorder</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">PROK2-related condition</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
          <TraitSet ID="9590" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16789" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">AllHighlyPenetrant</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not specified</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not specified' was created for use in ClinVar so that submitters can convey the concept that a variant is benign, likely benign, or of uncertain significance for an unspecified set of disorders.  This usage was introduced in 2014 to replace AllHighlyPenetrant.</Attribute>
              </AttributeSet>
              <XRef ID="CN169374" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="23950" SubmissionDate="2013-10-22" DateLastUpdated="2013-10-24" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="607002.0002_HYPOGONADOTROPIC HYPOGONADISM 4 WITH ANOSMIA" title="PROK2, 1-BP INS, 234T_HYPOGONADOTROPIC HYPOGONADISM 4 WITH ANOSMIA" />
        <ClinVarAccession Accession="SCV000023950" DateUpdated="2013-10-24" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2006-10-20">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In affected members of a family with manifestations of Kallmann syndrome-4 (HH4; 610628) in 4 generations, Dode et al. (2006) identified heterozygosity for a 1-nucleotide insertion, a T between nucleotides 234 and 235, in exon 4 of the PROK2 gene, predicted to result in a frameshift at codon 79 with a premature termination at codon 100 (79fsX100). The most recent generation of the family had 2 sisters with full Kallmann syndrome, a brother with hypogonadism only, and 3 unaffected sisters. The mother, maternal grandfather, and great grandfather had anosmia only. The mutation was not found in 500 alleles from ethnically matched (Caucasian) control individuals.</Attribute>
              <Citation>
                <ID Source="PubMed">17054399</ID>
              </Citation>
              <XRef DB="OMIM" ID="610628" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PROK2" />
          </GeneList>
          <Name>PROK2, 1-BP INS, 234T</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP INS, 234T</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="607002.0002" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">HYPOGONADOTROPIC HYPOGONADISM 4 WITH ANOSMIA</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1103679" SubmissionDate="2021-09-25" DateLastUpdated="2017-04-27" DateCreated="2017-04-27">
        <ClinVarSubmissionID localKey="GDXSV:156057" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV000568572" DateUpdated="2017-04-27" DateCreated="2017-04-27" Type="SCV" Version="3" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" OrgAbbreviation="GDX" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-11-12">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
          <Comment>Reported previously using alternate nomenclature (c.234_235insT) in the heterozygous state in one family with Kallmann syndrome, however, the family underwent sequencing for only two genes (Dode et al., 2006). Of the five family members heterozygous for the c.297dupT variant, one had anosmia only, another had hypogonadism only, two individuals had both hypogonadism and anosmia, and one individual was unaffected.; Frameshift variant in the C-terminus predicted to result in protein truncation, as the last 30 amino acids are lost and replaced with 21 incorrect amino acids; This variant is associated with the following publications: (PMID: 31200363, 17054399)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PROK2" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:702757</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001126128.1:c.297dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_51_20210925044204</SubmissionName>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4894951" SubmissionDate="2022-04-22" DateLastUpdated="2022-04-23" DateCreated="2022-04-23">
        <ClinVarSubmissionID localKey=":Chr.3_71821967_C_CA|Not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002501509" DateUpdated="2022-04-23" DateCreated="2022-04-23" Type="SCV" Version="1" SubmitterName="AiLife Diagnostics, AiLife Diagnostics" OrgID="507594" OrganizationCategory="laboratory" OrgAbbreviation="AiLife" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-06-16">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
          <Citation>
            <ID Source="PubMed">17054399</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31200363</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <TypePlatform>NGS</TypePlatform>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SecondaryFinding">no</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PROK2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="3" alternateAllele="CA" referenceAllele="C" start="71821967" stop="71821967" variantLength="1" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11350707</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7693720" SubmissionDate="2023-10-19" DateLastUpdated="2023-11-20" DateCreated="2023-11-20">
        <ClinVarSubmissionID localKey="1167530|PROK2-related condition" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004117541" DateUpdated="2023-11-20" DateCreated="2023-11-20" Type="SCV" Version="1" SubmitterName="PreventionGenetics, part of Exact Sciences" OrgID="239772" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-08-10">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
          <Comment>The PROK2 c.297dupT variant is predicted to result in a frameshift and premature protein termination (p.Gly100Trpfs*22). This variant is located in the last exon of PROK2, is not predicted to undergo nonsense mediated decay, and disrupts the final ~30 amino acids. This variant, also referred to as c.234_235insT (p.Asn79fs*100), has been reported in the heterozygous state in three siblings presenting with Kallmann syndrome; it was inherited from their affected mother and was also present in an asymptomatic sister (Dodé et al. 2006. PubMed ID: 17054399, Family E). This variant has also been reported in the homozygous (Patient #6) and heterozygous (Patient #45) state in individuals with Kallmann syndrome (Amato et al. 2019. PubMed ID: 31200363). This variant is observed in 31 out of ~282,370 alleles in a large population database (http://gnomad.broadinstitute.org/variant/3-71821967-C-CA). This variant has conflicting interpretations of pathogenicity of uncertain and pathogenic in ClinVar (https://www.ncbi.nlm.nih.gov/clinvar/variation/420068/). A premature protein termination variant (p.Arg122*) downstream of the one reported here has been reported in a patient with Kallmann syndrome (Sarfati et al. 2013. PubMed ID: 24031091). Although we suspect that this variant may be pathogenic, possibly for an autosomal recessive form of disease, the clinical significance of this variant is currently classified as uncertain due to the absence of conclusive functional and genetic evidence.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PROK2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001126128.1:c.297dupT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">PROK2-related condition</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13915440</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7701748" SubmissionDate="2023-11-14" DateLastUpdated="2023-11-20" DateCreated="2023-11-20">
        <ClinVarSubmissionID localKey="NM_001126128.2:c.297dupT|MedGen:CN169374" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004122042" DateUpdated="2023-11-20" DateCreated="2023-11-20" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-10-03">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
          <Citation>
            <ID Source="PubMed">17054399</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18682503</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31200363</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20022991</ID>
          </Citation>
          <Comment>Variant summary: PROK2 c.297dupT (p.Gly100TrpfsX22), located in the last exon of the gene, results in a premature termination codon and is predicted to cause a truncation of the encoded protein, but is not expected to undergo nonsense mediated decay. The variant allele was found at a frequency of 0.00011 in 251124 control chromosomes (gnomAD). c.297dupT has been reported in the literature in heterozygous and homozygous individuals affected with Kallmann Syndrome/Hypogonadotropic Hypogonadism 4 With Or Without Anosmia (e.g. Dode_2006, Abreu_2008, Amato_2019). In one family with a history of anosmia, the variant was found in the heterozygous state in five individuals, two with hypogonadism and anosmia, one with only hypogonadism, one with only anosmia, and one who was unaffected (Dode_2006). In another study, the variant was found in the homozygous state in two brothers with Kallmann Syndrome, although the parents were unavailable for testing and were reportedly unaffected (Abreu_2008). In both studies, only several genes related to the phenotype were sequenced. Therefore, these reports do not provide unequivocal conclusions about association of the variant with Kallmann Syndrome/Hypogonadotropic Hypogonadism 4 With Or Without Anosmia. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 31200363, 17054399, 20022991, 18682503). Two submitters have cited clinical-significance assessments for this variant to ClinVar after 2014 and both classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PROK2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001126128.2:c.297dupT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN169374" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13972740</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8631587" SubmissionDate="2024-02-07" DateLastUpdated="2024-02-28" DateCreated="2024-02-28">
        <ClinVarSubmissionID localKey="107833|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004675443" DateUpdated="2024-02-28" DateCreated="2024-02-28" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">17054399</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31200363</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Gly100Trpfs*22) in the PROK2 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 30 amino acid(s) of the PROK2 protein. This variant is present in population databases (rs768413190, gnomAD 0.02%). This premature translational stop signal has been observed in individuals with clinical features of Kallmann Syndrome (PMID: 17054399, 31200363). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 420068). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PROK2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000003.11:g.71821967_71821968insA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200269</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="8631587" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1103679" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="23950" TraitType="Disease" MappingType="Name" MappingValue="HYPOGONADOTROPIC HYPOGONADISM 4 WITH ANOSMIA" MappingRef="Preferred">
        <MedGen CUI="C3552343" Name="Hypogonadotropic hypogonadism 4 with or without anosmia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7701748" TraitType="Disease" MappingType="XRef" MappingValue="CN169374" MappingRef="MedGen">
        <MedGen CUI="CN169374" Name="not specified" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7693720" TraitType="Disease" MappingType="Name" MappingValue="PROK2-related condition" MappingRef="Preferred">
        <MedGen CUI="None" Name="PROK2-related disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4894951" TraitType="Disease" MappingType="Name" MappingValue="Not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

